High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation

Circ J. 2010 Jul;74(7):1316-21. doi: 10.1253/circj.cj-09-0708. Epub 2010 May 27.

Abstract

Background: It has been shown that the concentration of serum free thyroxine (FT(4)) is independently associated with atrial fibrillation (AF), even in euthyroid persons. This study investigated the effect of a high-normal level of FT(4) on recurrence after catheter ablation of AF.

Methods and results: The 244 consecutive patients with paroxysmal AF and who underwent circumferential pulmonary vein isolation (PVI) were prospectively enrolled. Exclusion criteria included prior or current thyroid dysfunction on admission, amiodarone medication for 3 months before admission. After a mean follow-up of 416+/-204 (91-856) days, the recurrence rates were 14.8%, 23.0%, 33.3%, 38.7% from the lowest FT(4) quartile to the highest FT(4) quartile, respectively (P=0.016). After adjustment for age, sex, left atrial diameter, and PVI, there was an increased risk of recurrence in the subjects with the highest FT(4) quartile compared with those with the lowest quartile (hazard ratio 3.31, 95% confidence interval 1.45-7.54, P=0.004). As a continuous variable, FT(4) was also an independent predictor of recurrence (hazard ratio 1.10, 95% confidence interval 1.02-1.18, P=0.016).

Conclusions: Patients with high-normal thyroid function were at an increased risk of AF recurrence after catheter ablation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Atrial Fibrillation / etiology*
  • Atrial Fibrillation / pathology
  • Catheter Ablation / adverse effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Observation
  • Predictive Value of Tests
  • Prospective Studies
  • Pulmonary Veins
  • Recurrence
  • Risk
  • Thyroid Gland / physiology*
  • Thyroxine / analogs & derivatives*
  • Thyroxine / blood

Substances

  • thyroxine sulfate
  • Thyroxine